Showing results (161-170 of 258) with videos related to
Sort By:
Pageof 26
Journal for Immunotherapy of Cancer|July 26, 2020
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responsesErika J Lampert, Ashley Cimino-Mathews, Joo Sang Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumorsJean L Grem, Geraldine Morrison, Xiao-Du Guo, et al.The Journal of Urology|November 20, 2015
Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor CellsEric C Kauffman, Min-Jung Lee, Sylvia V Alarcon, et al.Annals of Clinical and Laboratory Science|October 29, 2005
Histone deacetylase inhibitor pharmacodynamic analysis by multiparameter flow cytometryEun Joo Chung, Sunmin Lee, Edward A Sausville, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2019
Rebalancing Protein Homeostasis Enhances Tumor Antigen PresentationAlex M Jaeger, Lauren Stopfer, Sunmin Lee, et al.Nature Communications|January 19, 2018
Phosphorylation induced cochaperone unfolding promotes kinase recruitment and client class-specific Hsp90 phosphorylationAshleigh B Bachman, Dimitra Keramisanou, Wanping Xu, et al.Journal of Thrombosis and Haemostasis : JTH|February 6, 2020
Pharmacologic dissection of the overlapping impact of heat shock protein family members on platelet functionJoseph W Jackson, Genesis M Rivera-Marquez, Kristin Beebe, et al.Oncotarget|August 6, 2016
EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse modelsAbhilash Venugopalan, Min-Jung Lee, Gang Niu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitorDenise A Yardley, Roohi R Ismail-Khan, Bohuslav Melichar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Genetic basis of cancer of the kidney: disease-specific approaches to therapyW Marston Linehan, James Vasselli, Ramaprasad Srinivasan, et al.Pageof 26